Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate.
The mean serum high density lipoprotein cholesterol (HDL-C) concentration proved to be significantly lower in 23 women taking depot-medroxyprogesterone acetate (DMPA) as a twelve-weekly injectable contraceptive for at least 1 year, as compared to 23 IUD users. In the DMPA group, no significant difference was found in the mean serum HDL-C concentration, when measured 2, 6 and 12 weeks after a DMPA injection.
D002784:Cholesterol / Q000097:blood*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D013997:Time Factors
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D008075:Lipoproteins, HDL; D002784:Cholesterol; D008525:Medroxyprogesterone